PRTN3 and arthritic joint disease: It is assumed that much of genetic risk associated with RA development is captured through the development of antibodies [61]; however, it remains unclear if relatives of RA patients with ACPA positivity have the same risk of arthritis as individuals with ACPA positivity who do not have a relative with RA.